Nalaganje...

Sustained complete response to erlotinib in squamous cell carcinoma of the head and neck: A case report

BACKGROUND: Squamous cell carcinoma of head and neck (SCCHN) is the fifth most common cancer worldwide. Inhibition of epidermal growth factor receptor signaling has been shown to be a critical component of therapeutic option. Herein, we report a case of durable complete response to erlotinib. CASE S...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:World J Clin Cases
Main Authors: Thinn, Mie Mie, Hsueh, Chung-Tzu, Hsueh, Chung-Tsen
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6406195/
https://ncbi.nlm.nih.gov/pubmed/30863760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v7.i5.616
Oznake: Označite
Brez oznak, prvi označite!